{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T03:09:17Z","timestamp":1789614557749,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2024A1515011705"],"award-info":[{"award-number":["2024A1515011705"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002920","name":"University Grants Committee Research Grants Council","doi-asserted-by":"publisher","award":["14107719"],"award-info":[{"award-number":["14107719"]}],"id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.apsb.2026.03.023","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T10:18:44Z","timestamp":1773829124000},"page":"3059-3073","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Red blood cell damage defines the etiology of hepatic sinusoidal obstruction syndrome induced by pyrrolizidine alkaloids"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2835-5730","authenticated-orcid":false,"given":"Zijing","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yisheng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8415-6001","authenticated-orcid":false,"given":"Wei","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5715-1657","authenticated-orcid":false,"given":"Yueyang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5522-5285","authenticated-orcid":false,"given":"Tianyang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzheng","family":"Zhuge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2026.03.023_bib1","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1002\/hep.510290615","article-title":"Characterization of a reproducible rat model of hepatic veno-occlusive disease","volume":"29","author":"DeLeve","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2026.03.023_bib2","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0168-8278(03)00231-9","article-title":"Hepatic sinusoidal-obstruction syndrome: toxicity of pyrrolizidine alkaloids","volume":"39","author":"Chojkier","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2026.03.023_bib3","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41409-023-01992-8","article-title":"Diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in adult patients: a refined classification from the European society for blood and marrow transplantation (EBMT)","volume":"58","author":"Mohty","year":"2023","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.apsb.2026.03.023_bib4","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.bbmt.2019.02.018","article-title":"Risk factors for development of and progression of hepatic veno-occlusive disease\/sinusoidal obstruction syndrome","volume":"25","author":"Corbacioglu","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.apsb.2026.03.023_bib5","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.3748\/wjg.v25.i28.3753","article-title":"Pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome: pathogenesis, clinical manifestations, diagnosis, treatment, and outcomes","volume":"25","author":"Yang","year":"2019","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.apsb.2026.03.023_bib6","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/s41401-020-00553-9","article-title":"Tu-San-Qi (Gynura japonica): the culprit behind pyrrolizidine alkaloid-induced liver injury in China","volume":"42","author":"Zhu","year":"2021","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.apsb.2026.03.023_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2019.111107","article-title":"Pyrrolizidine alkaloids in food and phytomedicine: occurrence, exposure, toxicity, mechanisms, and risk assessment\u2014a review","volume":"136","author":"Schrenk","year":"2020","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.apsb.2026.03.023_bib8","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1080\/19440049.2010.541594","article-title":"Pyrrolizidine alkaloids in honey and bee pollen","volume":"28","author":"Dubecke","year":"2011","journal-title":"Food Addit Contam Part A Chem Anal Control Expo Risk Assess"},{"key":"10.1016\/j.apsb.2026.03.023_bib9","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0140-6736(76)90726-1","article-title":"An outbreak of hepatic veno-occlusive disease in north-western Afghanistan","volume":"2","author":"Mohabbat","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.apsb.2026.03.023_bib10","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jhep.2013.07.039","article-title":"Hirmi Valley liver disease: a disease associated with exposure to pyrrolizidine alkaloids and DDT","volume":"60","author":"Robinson","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2026.03.023_bib11","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/0140-6736(93)90798-L","article-title":"Heliotrope poisoning in Tadjikistan","volume":"341","author":"Chauvin","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.apsb.2026.03.023_bib12","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0140-6736(76)90727-3","article-title":"An epidemic of veno-occlusive disease of liver in central India","volume":"2","author":"Tandon","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.apsb.2026.03.023_bib13","article-title":"Tusanqi-related sinusoidal obstruction syndrome in China: a systematic review of the literatures","volume":"94","author":"Wang","year":"2015","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.apsb.2026.03.023_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1081\/DMR-120028426","article-title":"Pyrrolizidine alkaloids\u2014genotoxicity, metabolism enzymes, metabolic activation, and mechanisms","volume":"36","author":"Fu","year":"2004","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.apsb.2026.03.023_bib15","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jhep.2010.07.031","article-title":"Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum","volume":"54","author":"Lin","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2026.03.023_bib16","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1021\/acs.chemrestox.8b00369","article-title":"Pyrrole\u2013hemoglobin adducts, a more feasible potential biomarker of pyrrolizidine alkaloid exposure","volume":"32","author":"Ma","year":"2019","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.apsb.2026.03.023_bib17","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.jfda.2018.05.005","article-title":"Pyrrole\u2013protein adducts\u2014a biomarker of pyrrolizidine alkaloid-induced hepatotoxicity","volume":"26","author":"Ma","year":"2018","journal-title":"J Food Drug Anal"},{"key":"10.1016\/j.apsb.2026.03.023_bib18","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/jgh.14612","article-title":"Expert consensus on the clinical management of pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome","volume":"34","author":"Zhuge","year":"2019","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2026.03.023_bib19","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00204-023-03443-1","article-title":"Targeting erythrocyte-mediated hypoxia to alleviate lung injury induced by pyrrolizidine alkaloids","volume":"97","author":"Song","year":"2023","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.apsb.2026.03.023_bib20","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3390\/toxins14060377","article-title":"Correlation investigation between pyrrole\u2013DNA and pyrrole\u2013protein adducts in male ICR mice exposed to retrorsine, a hepatotoxic pyrrolizidine alkaloid","volume":"14","author":"Zhu","year":"2022","journal-title":"Toxins"},{"key":"10.1016\/j.apsb.2026.03.023_bib21","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3390\/toxins11110660","article-title":"Hemolysis derived products toxicity and endothelium: model of the second hit","volume":"11","author":"Frimat","year":"2019","journal-title":"Toxins"},{"key":"10.1016\/j.apsb.2026.03.023_bib22","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1111\/j.1538-7836.2006.02205.x","article-title":"Acute activation of the endothelium results in increased levels of active von Willebrand factor in hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome","volume":"4","author":"Hulstein","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.apsb.2026.03.023_bib23","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1038\/cdd.2013.113","article-title":"Mechanisms of haptoglobin protection against hemoglobin peroxidation triggered endothelial damage","volume":"20","author":"Schaer","year":"2013","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.apsb.2026.03.023_bib24","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1007\/s00204-022-03329-8","article-title":"Optimisation of the HepaRG cell line model for drug toxicity studies using two different cultivation conditions: advantages and limitations","volume":"96","author":"Hammour","year":"2022","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.apsb.2026.03.023_bib25","first-page":"127","article-title":"Immunoassay approach for diagnosis of exposure to pyrrolizidine alkaloids","volume":"35","author":"Li","year":"2017","journal-title":"J Environ Sci Health C Environ Carcinog Ecotoxicol Rev"},{"key":"10.1016\/j.apsb.2026.03.023_bib26","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1021\/ci500175r","article-title":"Structure-based virtual screening approach for discovery of covalently bound ligands","volume":"54","author":"Toledo Warshaviak","year":"2014","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.apsb.2026.03.023_bib27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/978-1-0716-1209-5_4","article-title":"Binding mode prediction and virtual screening applications by covalent docking","volume":"2266","author":"Scarpino","year":"2021","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.apsb.2026.03.023_bib28","first-page":"352","article-title":"Measurement and clinical usefulness of bilirubin in liver disease","volume":"2","author":"Guerra Ruiz","year":"2021","journal-title":"Adv Lab Med"},{"key":"10.1016\/j.apsb.2026.03.023_bib29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000508711","article-title":"Hemolysis pathways during storage of erythrocytes and inter-donor variability in erythrocyte morphology","volume":"48","author":"Melzak","year":"2021","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.apsb.2026.03.023_bib30","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/ijlh.13689","article-title":"Blister and bite cells in G6PD deficiency","volume":"44","author":"Opsahl","year":"2022","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.apsb.2026.03.023_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101971","article-title":"HO-1-mediated ferroptosis as a target for protection against retinal pigment epithelium degeneration","volume":"43","author":"Tang","year":"2021","journal-title":"Redox Biol"},{"key":"10.1016\/j.apsb.2026.03.023_bib32","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","article-title":"Ferroptosis: molecular mechanisms and health implications","volume":"31","author":"Tang","year":"2021","journal-title":"Cell Res"},{"key":"10.1016\/j.apsb.2026.03.023_bib33","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.bbrc.2016.08.124","article-title":"Identification of ACSL4 as a biomarker and contributor of ferroptosis","volume":"478","author":"Yuan","year":"2016","journal-title":"Biochem Bioph Res Co"},{"key":"10.1016\/j.apsb.2026.03.023_bib34","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/clinchem\/44.1.40","article-title":"Serum transferrin receptors are decreased in the presence of iron overload","volume":"44","author":"Khumalo","year":"1998","journal-title":"Clin Chem"},{"key":"10.1016\/j.apsb.2026.03.023_bib35","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.3390\/genes12091364","article-title":"The multiple facets of iron recycling","volume":"12","author":"Slusarczyk","year":"2021","journal-title":"Genes"},{"key":"10.1016\/j.apsb.2026.03.023_bib36","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jhep.2010.12.003","article-title":"Herbal medicine hepatotoxicity: a new step with development of specific biomarkers","volume":"54","author":"Larrey","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2026.03.023_bib37","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.jhep.2019.02.014","article-title":"EASL clinical practice guidelines: drug-induced liver injury","volume":"70","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2026.03.023_bib38","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S2468-1253(24)00324-8","article-title":"Herbal and dietary supplements: unregulated hepatotoxicity","volume":"9","author":"The Lancet Gastroenterology","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2026.03.023_bib39","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.apsb.2018.12.003","article-title":"Guidance for the clinical evaluation of traditional Chinese medicine-induced liver injury issued by China Food and Drug Administration","volume":"9","author":"Xiao","year":"2019","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2026.03.023_bib40","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3390\/toxins13100723","article-title":"Pyrrolizidine alkaloid-induced hepatotoxicity associated with the formation of reactive metabolite-derived pyrrole\u2013protein adducts","volume":"13","author":"Ma","year":"2021","journal-title":"Toxins"},{"key":"10.1016\/j.apsb.2026.03.023_bib41","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.cbi.2015.09.011","article-title":"Cytotoxicity of pyrrolizidine alkaloid in human hepatic parenchymal and sinusoidal endothelial cells: firm evidence for the reactive metabolites mediated pyrrolizidine alkaloid-induced hepatotoxicity","volume":"243","author":"Yang","year":"2016","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.apsb.2026.03.023_bib42","doi-asserted-by":"crossref","first-page":"3820","DOI":"10.1016\/j.apsb.2021.07.013","article-title":"The key role of gut\u2013liver axis in pyrrolizidine alkaloid-induced hepatotoxicity and enterotoxicity","volume":"11","author":"He","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2026.03.023_bib43","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00204-020-02921-0","article-title":"Lung injury induced by pyrrolizidine alkaloids depends on metabolism by hepatic cytochrome P450s and blood transport of reactive metabolites","volume":"95","author":"He","year":"2021","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.apsb.2026.03.023_bib44","first-page":"219","article-title":"Morphologic changes in red blood cells: an illustrated review of clinically important light microscopic findings","volume":"43","author":"Tyrrell","year":"2021","journal-title":"Malays J Pathol"},{"key":"10.1016\/j.apsb.2026.03.023_bib45","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0002-9343(92)90071-I","article-title":"Drug-associated \"bite cell\" hemolytic anemia","volume":"92","author":"Yoo","year":"1992","journal-title":"Am J Med"},{"key":"10.1016\/j.apsb.2026.03.023_bib46","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1179\/135100001101536364","article-title":"Role of haptoglobin in free hemoglobin metabolism","volume":"6","author":"Lim","year":"2001","journal-title":"Redox Rep"},{"key":"10.1016\/j.apsb.2026.03.023_bib47","doi-asserted-by":"crossref","first-page":"L429","DOI":"10.1152\/ajplung.00018.2021","article-title":"Toxic effects of cell-free hemoglobin on the microvascular endothelium: implications for pulmonary and nonpulmonary organ dysfunction","volume":"321","author":"Meegan","year":"2021","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.apsb.2026.03.023_bib48","first-page":"500","article-title":"The pathophysiology of extracellular hemoglobin associated with enhanced oxidative reactions","volume":"5","author":"Rifkind","year":"2014","journal-title":"Front Physiol"},{"key":"10.1016\/j.apsb.2026.03.023_bib49","doi-asserted-by":"crossref","first-page":"e296","DOI":"10.1016\/j.lpm.2017.10.007","article-title":"Iron overload in hematological disorders","volume":"46","author":"Fibach","year":"2017","journal-title":"Presse Med"},{"key":"10.1016\/j.apsb.2026.03.023_bib50","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1021\/acscentsci.7b00028","article-title":"On the mechanism of cytoprotection by Ferrostatin-1 and Liproxstatin-1 and the role of lipid peroxidation in ferroptotic cell death","volume":"3","author":"Zilka","year":"2017","journal-title":"ACS Cent Sci"},{"key":"10.1016\/j.apsb.2026.03.023_bib51","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12876-020-1180-0","article-title":"Clinical characteristics, CT signs, and pathological findings of pyrrolizidine alkaloids-induced sinusoidal obstructive syndrome: a retrospective study","volume":"20","author":"Liu","year":"2020","journal-title":"BMC Gastroenterol"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383526001796?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383526001796?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T01:45:41Z","timestamp":1779414341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383526001796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2211383526001796"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2026.03.023","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Red blood cell damage defines the etiology of hepatic sinusoidal obstruction syndrome induced by pyrrolizidine alkaloids","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2026.03.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}